This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Management of oropharyngeal squamous carcinoma

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Squamous carcinomas of oropharynx

T1-2 N0 tumours of the oropharynx.

  • the choice of transoral surgical resection or primary radiotherapy should be offered
  • postoperative radiotherapy, with or without concomitant chemotherapy, should be considered if pathologically adverse risk factors have been identified.

Human pavillomavirus-related disease

  • if squamous cell carcinomas of the oropharynx then test using p16 immunohistochemistry
    • p16 test result should be considered as positive only if there is strong nuclear and cytoplasmic staining in more than 70% of tumour cells
    • high-risk HPV DNA or RNA in-situ hybridisation should be considered in all p16-positive cancers of the oropharynx to confirm HPV status.

Reference:

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page